# Myocardial Fibrosis Progression in Duchenne and Becker Muscular Dystrophy - ACE Inhibitor Therapy Trial

> **NCT02432885** · PHASE3 · COMPLETED · sponsor: **InCor Heart Institute** · enrollment: 76 (actual)

## Conditions studied

- Myocardial Fibrosis
- Muscular Dystrophies

## Interventions

- **DRUG:** Enalapril

## Key facts

- **NCT ID:** NCT02432885
- **Lead sponsor:** InCor Heart Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06
- **Primary completion:** 2012-06
- **Final completion:** 2013-06
- **Target enrollment:** 76 (ACTUAL)
- **Last updated:** 2015-05-04

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02432885

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02432885, "Myocardial Fibrosis Progression in Duchenne and Becker Muscular Dystrophy - ACE Inhibitor Therapy Trial". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02432885. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*